Explore new findings on frailty in systemic sclerosis, revealing its prevalence, dynamic progression, and impact on patient ...

Frailty among patients with systemic sclerosis significantly increases the risk for mortality by nearly 10-fold, but shows ...

The following is a summary of “An exploratory analysis of differences in serum protein expression by sex in patients with ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

A history of infertility without fertility treatment was associated with a higher future risk of SARD, independent of ...

Objective Juvenile SLE (jSLE) is an autoimmune disease characterised by the presence of high levels of autoantibodies, ...

Rapcabtagene autoleucel is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

2011 Expert Reviews Ltd. Epigenetic modifications of gene expression offer novel therapeutic strategies for the treatment of patients with systemic sclerosis (SSc). Epigenetic modifications such ...

By all accounts, cold hands are often dismissed as a minor inconvenience or a reaction to chilly weather. However, for Scott Nell, a 47-year-old father from Houghton-le-Spring, England, this seemingly ...

So long as our institutes of higher learning remain ideological monocultures, they're likely to put ideological interests ahead of their own self-interests You can save this article by registering ...

Despite the improved survival among patients with the serious form of scleroderma (systemic sclerosis; SSc), diffuse cutaneous SSc (dcSSc), over the last decade, there is a significant morbidity ...